Aldeyra Therapeutics, Inc. (ALDX)
1.83
+0.04
(+2.23%)
USD |
NASDAQ |
Apr 15, 16:00
1.835
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics Research and Development Expense (Annual) : 25.66M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Rhythm Pharmaceuticals, Inc. | 166.90M |
| Pfizer Inc. | 10.25B |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| MediciNova, Inc. | 7.135M |
| Altimmune, Inc. | 66.32M |